The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Harris Geoffrey E. since 2015.
This trader's CIK number is 1611395.
At the time of last reporting, Harris Geoffrey E. was the Officer of Vyant Bio, Inc.. (stock ticker symbol VYNT).
Also see all insider trading activities at Vyant Bio, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2017 | MYND | 4,552 | $17,399 | 0 | $0 | 0 | $0 |
2016 | MYND | 0 | $0 | 0 | $0 | 2,058 | $10,290 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | VYNT | 0 | $0 | 765 | $1,022 | 0 | $0 |
2019 | VYNT | 100,000 | $22,500 | 0 | $0 | 0 | $0 |
2017 | VYNT | 2,500 | $9,375 | 0 | $0 | 0 | $0 |
2016 | VYNT | 7,500 | $11,500 | 0 | $0 | 0 | $0 |
2015 | VYNT | 5,000 | $53,949 | 0 | $0 | 0 | $0 |
1. Emmaus Life Sciences, Inc. (MYND)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2017-12-06 | MYND | Buy | 4,500 | 3.83 | 17,212 |
2017-12-05 | MYND | Buy | 52 | 3.60 | 187 |
2016-09-21 | CNSO | Option Ex | 2,058 | 5.00 | 10,290 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-11-18 | VYNT | Sale | 765 | 1.34 | 1,022 |
2019-01-14 | CGIX | Buy | 100,000 | .23 | 22,500 |
2017-05-16 | CGIX | Buy | 2,500 | 3.75 | 9,375 |
2016-12-14 | CGIX | Buy | 2,500 | 1.50 | 3,750 |
2016-11-14 | CGIX | Buy | 5,000 | 1.55 | 7,750 |
2015-05-14 | CGIX | Buy | 5,000 | 10.79 | 53,949 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Harris Geoffrey E. (Officer of Vyant Bio, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.